Research Article
Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study
Table 3
Comparisons of offspring of pregnant mothers infected with hepatitis B virus among three groups.
| | Variable | LAM group () | LdT group () | Control group () | |
| | Gestational age (weeks) | | | | 0.088 | | Gender (male/female) | 192/174 | 685/613 | 530/454 | 0.842 | | Infant weight (g) | | | | 0.523 | | Infant length (cm) | | | | 0.624 | | Premature birth/low birth weight (%) | 15 (4.1) | 56 (4.3) | 39 (4.0) | 0.916 | | Birth abnormalities (%) | 9 (2.5) | 26 (2.0) | 33 (3.4) | 0.129 | | Apgar at 1 min | 10 (3, 10) | 10 (5, 10) | 10 (4, 10) | 0.081 | | Apgar at 5 min | 10 (3, 10) | 10 (7, 10) | 10 (5, 10) | 0.314 | | Apgar at 10 min | 10 (3, 10) | 10 (8, 10) | 10 (3, 10) | 0.571 |
|
|
Birth abnormalities include birth defects, stillbirth, and death within 24 hours of birth.
|
